Charles M. Rudin
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Charles M. Rudin
Oct 12, 2024, 22:16 |
Insight
Triparna Sen: CD38-mediated immunosuppression as a potential mechanism of tumor cell escape from PDL1 inhibition in SCLC
Triparna Sen, Associate Professor, Icahn School of Medicine at Mount Sinai, shared a post on…
Jul 26, 2024, 00:16 |
Insight
Impact of the intratumoral microbiome of NSCLC on outcomes with immunotherapy
Stephen Liu shared on X: "Impressive work on impact of the intratumoral microbiome of NSCLC…
Jul 25, 2024, 00:32 |
Blog
Jarushka Naidoo: Can intratumor eschericia improve OS from ICIs in NSCLC
Jarushka Naidoo shared a post on X: ''Can intratumor eschericia (E) bring immune cells to…
Apr 26, 2024, 20:26 |
Insight
New Paper Alert! Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial
Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial Authors:…
All:
4
Posts:
1 - 100
ESTRO: Everything You Need to Know About European Society for Radiotherapy and Oncology
Jane Fonda Breast Cancer and Non-Hodgkin Lymphoma: How She Went Against, How She Survived, and More
Inside OncoDaily Party Barcelona
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube